AGN 4.65% 61.5¢ argenica therapeutics limited

ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-2

  1. 34,304 Posts.
    lightbulb Created with Sketch. 8997
    It's an interesting bio.
    The nearest competitor, NA1 (NoNo) is currently on Phase 3 trial (expected to completed December 2020).
    But AGN's is still pre-clinical.
    It takes NoNo 8 years from Phase 1 to Phase 3.
    I think it's a long way to go.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
(20min delay)
Last
61.5¢
Change
-0.030(4.65%)
Mkt cap ! $75.53M
Open High Low Value Volume
64.5¢ 64.5¢ 60.0¢ $73.94K 120.9K

Buyers (Bids)

No. Vol. Price($)
2 27960 61.0¢
 

Sellers (Offers)

Price($) Vol. No.
61.5¢ 18424 1
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
61.5¢
  Change
-0.030 ( 3.91 %)
Open High Low Volume
62.5¢ 62.5¢ 60.0¢ 57573
Last updated 15.10pm 09/05/2024 ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.